Faculty Information |
|
Article types | Original article |
Language | English |
Refereed paper | Refereed |
Title | Comparing the impact of atezolizumab plus bevacizumab and lenvatinib on the liver function in hepatocellular carcinoma patients: A mixed-effects regression model approach |
Journal | Formal name:Cancer Medicine |
Domestic / Foregin | Foregin |
Volume, Number, Page | 12(24),pp.21680-21693 |
Papers・Author | Hatanaka Takeshi, Satoru , Atsushi ,Tada Toshifumi, Hirooka Masashi ,Kariyama Kazuya, Tani Joji, Atsukawa Msanori, Takaguchi Koichi, Itobayashi Ei, Fukunishi Shinya, Tsuji Kunihiko, Ishikawa Toru, Tajiri Kazuto, Ochi Hironori, Yasuda Satoshi, Toyoda Hidenori, Ogawa Chikara, Yokohama Keisuke, Nishikawa Hiroki, Nishimura Takashi, ShimadaNoritomo, Kawata Kazuhito, Kosaka Hisashi,Naganuma Atsushi, Yata Ytaka, Ohama Hideko,Kuroda Hidekatsu,Tanaka Kazunori, Tanaka Takaaki, Tada Fujimasa, Nouso Kazuhiro, Morishita Asahiro, Tsutsui Akemi,Nagano Takuya,Itokawa Norio,Okubo Tomoko, Arai Taeang, Imai Michitaka,Koizumi Yohei, Nakamura Shinichiro, Kaibori Masaki, Iijima Hiroko, Hiasa Yoichi, Kudo Masatoshi, Kumada Takashi.the Real-life Practice Experts for HCC (RELPEC) Study Group, and HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan) |
Publication date | 2023/12 |